Predicted protein targets (top 3)
| gene | UniProt | supporting neighbours | confidence | |
|---|---|---|---|---|
| ▸ | CYP1A2 | P05177 | 1/20 | 0.41 |
| ▸ | CYP2D6 | P10635 | 1/20 | 0.41 |
| ▸ | CYP2C19 | P33261 | 1/20 | 0.41 |
Click a target to see other patent compounds predicted against it — the reverse direction, in place.
Similar compounds — the chemically nearest patent molecules
Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.
| Compound | similarity | top predicted | shared targets | |
|---|---|---|---|---|
| SCHEMBL18553329 | 0.79 | CYP1A2 (0.43) | CYP1A2CYP2D6CYP2C19 | |
| SCHEMBL8352086 | 0.79 | CYP1A2 (0.43) | CYP1A2CYP2D6CYP2C19 | |
| SCHEMBL2333576 | 0.78 | — | — | |
| SCHEMBL27021173 | 0.77 | CYP1A2 (0.42) | CYP1A2CYP2D6CYP2C19 | |
| SCHEMBL27730766 | 0.75 | CYP1A2 (0.41) | CYP1A2CYP2D6CYP2C19 | |
| SCHEMBL1741582 | 0.73 | CYP1A2 (0.40) | CYP1A2CYP2D6CYP2C19 | |
| SCHEMBL18149037 | 0.73 | CYP1A2 (0.40) | CYP1A2CYP2D6CYP2C19 | |
| SCHEMBL26688048 | 0.73 | CYP1A2 (0.43) | CYP1A2CYP2D6CYP2C19 | |
| SCHEMBL13339780 | 0.72 | — | — | |
| SCHEMBL2845756 | 0.70 | — | — |
Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.
Patent provenance — the patents this molecule appears in, and who filed them
Claimed or disclosed in 3 patents. claimed = in the patent's claims; disclosed = body only.
| Patent | Title | Assignee | Published | Priority | Filing | Country | Status |
|---|---|---|---|---|---|---|---|
| US-20140178503-A1 | CYCLOHEXYL UREA MODULATORS OF D2 RECEPTORS AND/OR D3 RECEPTORS | AUSPEX PHARMACEUTICALS, INC. (US) | 2014-06-26 | — | — | US | disclosed |
| US-7714155-B2 | Alkoxide compound, material for thin film formation, and process for thin film formation | ADEKA CORPORATION (JP) | 2010-05-11 | — | — | US | disclosed |
| US-20090035464-A1 | Alkoxide compound, material for thin film formation, and process for thin film formation | ADEKA CORPORATION (JP) | 2009-02-05 | — | — | US | disclosed |
Patent text — is the patent's own abstract consistent with the prediction?
For each of this compound's patents that has machine-readable text (2 of them — usually the abstract, not the full specification), we ask MedCPT which protein the text reads most about, and where the chemistry-predicted target lands among 4885 human targets. A high rank means the patent's own wording is consistent with the prediction — a weak, independent signal, not proof of activity.
| Patent | Title | Text reads most about | Predicted target · text-rank |
|---|---|---|---|
| US-20090035464-A1 | Alkoxide compound, material for thin film formation, and process for thin film formation | ALKBH5, ALKBH3, ALK | CYP1A2 476/4885CYP2D6 1550/4885CYP2C19 1267/4885 |
| US-20140178503-A1 | CYCLOHEXYL UREA MODULATORS OF D2 RECEPTORS AND/OR D3 RECEPTORS | UTS2R, VDR, PTGDR | CYP1A2 1569/4885CYP2D6 798/4885CYP2C19 1470/4885 |
“Text reads most about” is the patent abstract's nearest protein in MedCPT space (background-debiased). Only ~1.4% of patents have machine-readable text, so most compounds won't have this panel.